Shenlian extract attenuates myocardial ischaemia-reperfusion injury via inhibiting M1 macrophage polarization by silencing miR-155.

Abstract

CONTEXT:

Shenlian extract (SL) is a combination of Salvia miltiorrhiza Bge. (Labiatae) and Andrographis paniculata (Burm. F.) Wall. Ex Nees (Acanthaceae) extracts, which promote blood circulation and clear endogenous heat toxins. Myocardial ischaemia-reperfusion injury (MI/RI) is aggravated myocardial tissue damage induced by reperfusion therapy after myocardial infarction.

OBJECTIVES:

This study explores the effect of SL on MI/RI and the underlying mechanism.

MATERIALS AND METHODS:

Primary peritoneal macrophages (pMACs) were treated with LPS and SL (5, 10 or 20 μg/mL) for 24 h. The myocardial ischaemia-reperfusion (MI/R) model was established after administration of different doses of SL (90, 180 or 360 mg/kg). Myocardial tissue injury was assessed by methylthiazolyl tetrazolium (TTC) staining and levels of creatine kinase (CK), lactate dehydrogenase (LDH) and superoxide dismutase (SOD) in mice. The double immunofluorescence staining of iNOS/F4/80 and CD86/F4/80 was used to detect macrophage M1 polarization. The levels of miR-155, inflammatory factors and chemokines were detected by qRT-PCR or ELISA. CD86, iNOS, SOCS3, JAK2, p-JAK2, STAT3 and p-STAT3 proteins expressions in macrophages were analyzed by western blotting. Conditioned medium transfer systems were designed to unite M1 macrophages with H/R cardiomyocytes, and cell apoptosis was detected by TUNEL staining, western blotting or immunohistochemistry.

RESULTS:

SL reduced apoptosis, diminished CK and LDH levels, raised SOD concentration and decreased infarct size in the MI/R model. Meanwhile, SL decreased miR-155 level, inhibited M1 macrophage polarization and inflammation. Furthermore, SL promoted SOCS3 expression and blocked JAK2/STAT3 pathway in vitro.

CONCLUSIONS:

SL may be a promising TCM candidate for MI/RI. The underlying mechanisms could be associated with inhibition of M1 macrophage polarization via down-regulating miR-155.

• Authors: Min Song, Xihe Cui, Jing Zhang, Yujie Li, Jingjing Li, Yuanlong Zang, Qi Li, Qing Yang, Ying Chen, Weiyan Cai, Xiaogang Weng, Yajie Wang, Xiaoxin Zhu
• Journal: Pharmaceutical biology (Pharm Biol) Vol. 60 Issue 1 Pg. 2011-2024 (Dec 2022) ISSN: 1744-5116 [Electronic] England
• PMID: 36239618 (Publication Type: Journal Article)

Chemical References

• Culture Media, Conditioned
• Lipopolysaccharides
• MicroRNAs
• Mirn155 microRNA, mouse
• Lactate Dehydrogenases
• Superoxide Dismutase
• Creatine Kinase

Topics

• Animals
• Apoptosis
• Creatine Kinase (metabolism, pharmacology, therapeutic use)
• Culture Media, Conditioned (metabolism)
• Lactate Dehydrogenases (metabolism)
• Lipopolysaccharides (pharmacology)
• Macrophages (metabolism)
• Mice
• MicroRNAs (genetics, metabolism)
• Myocardial Reperfusion Injury (drug therapy, metabolism)
• Myocytes, Cardiac (metabolism)
• Superoxide Dismutase (metabolism)